These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32317681)
1. Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity. Alshamsan A; Binkhathlan Z; Kalam MA; Qamar W; Kfouri H; Alghonaim M; Lavasanifar A Sci Rep; 2020 Apr; 10(1):6675. PubMed ID: 32317681 [TBL] [Abstract][Full Text] [Related]
2. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity. Zhao L; Zhou Y; Gao Y; Ma S; Zhang C; Li J; Wang D; Li X; Li C; Liu Y; Li X Int J Pharm; 2015 Apr; 483(1-2):180-7. PubMed ID: 25681723 [TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related]
4. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273 [TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
8. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody. Eivazi N; Rahmani R; Paknejad M Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796 [TBL] [Abstract][Full Text] [Related]
9. Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis. Yu H; Lin T; Chen W; Cao W; Zhang C; Wang T; Ding M; Zhao S; Wei H; Guo H; Zhao X Biomaterials; 2019 Oct; 219():119368. PubMed ID: 31349200 [TBL] [Abstract][Full Text] [Related]
10. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related]
11. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin. Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection. Deng C; Jin Q; Wu Y; Li H; Yi L; Chen Y; Gao T; Wang W; Wang J; Lv Q; Yang Y; Xu J; Fu W; Zhang L; Xie M Drug Deliv; 2021 Dec; 28(1):1759-1768. PubMed ID: 34463172 [TBL] [Abstract][Full Text] [Related]
13. Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection. Wu Q; Liu D; Zhang X; Wang D; DongYe M; Chen W; Lin D; Zhu F; Chen W; Lin H Drug Deliv; 2019 Dec; 26(1):290-299. PubMed ID: 30895841 [TBL] [Abstract][Full Text] [Related]
14. Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival. Deng C; Chen Y; Zhang L; Wu Y; Li H; Wu Y; Wang B; Sun Z; Li Y; Lv Q; Yang Y; Wang J; Jin Q; Xie M Int J Pharm; 2020 Feb; 575():118951. PubMed ID: 31843550 [TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of tacrolimus to T cells by pH-responsive aptamer-chitosan- poly(lactic-co-glycolic acid) nanocomplex. Mansouri A; Abnous K; Alibolandi M; Taghdisi SM; Ramezani M J Cell Physiol; 2019 Aug; 234(10):18262-18271. PubMed ID: 30883749 [TBL] [Abstract][Full Text] [Related]
16. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced. Song X; Wang J; Xu Y; Shao H; Gu J Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model. Seo J; Lee C; Hwang HS; Kim B; Thao le Q; Lee ES; Oh KT; Lim JL; Choi HG; Youn YS Pulm Pharmacol Ther; 2016 Feb; 36():53-61. PubMed ID: 26768967 [TBL] [Abstract][Full Text] [Related]
18. Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis. Yang Y; Ding Y; Fan B; Wang Y; Mao Z; Wang W; Wu J J Control Release; 2020 May; 321():463-474. PubMed ID: 32087302 [TBL] [Abstract][Full Text] [Related]
19. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes. Kalam MA; Alshamsan A Biomed Pharmacother; 2017 Oct; 94():402-411. PubMed ID: 28772219 [TBL] [Abstract][Full Text] [Related]
20. Effects of surface modification of As Song X; You J; Shao H; Yan C Colloids Surf B Biointerfaces; 2018 Sep; 169():289-297. PubMed ID: 29793091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]